[1]
K. J. Khaleel, “Hematological events and thyroid status in Imatinib treated CML Iraqi”, Iraqi j. cancer med. genet., vol. 9, no. 2, Dec. 2016, doi: 10.29409/ijcmg.v9i2.184.